Select Your Location:
Global
France
Italy

Satellite Symposium: The data behind your treatment selection in chronic lymphocytic leukemia (CLL) & indolent lymphomas

Disease State: B-cell malignancies

Clemens Wendtner, Renata Walewska, Pier Luigi Zinzani, Matthew Davids

Overview of the treatment options for treatment naive (TN) and relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL) and the use of BTKis in indolent lymphomas presented at the EHA2024 Hybrid Congress.

Video
26 May 2025

A global congress digest on targeted therapies in B-cell malignancies covering updates from recent studies presented at EHA2024.

Reading
26 May 2025
Please login or register to access the download

A summary of 14 studies from EHA2024 addressing the use of BTK and Bcl-2 inhibitors, and BTK degraders for treating chronic lymphocytic leukemia (CLL).

Slide-Kit
26 May 2025
Please login or register to access the download

29 Apr 2025

29 Apr 2025